Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41,018 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults.
He S, Yu Y, Huang J, Yin J, Niu Y, Lu Y, Wu B, Fang M, Wang X, Tao Z, Li L, Li K, Li Y, Ding X, Shen Y, Li H. He S, et al. Among authors: yu y. Ther Adv Psychopharmacol. 2023 Nov 22;13:20451253231212342. doi: 10.1177/20451253231212342. eCollection 2023. Ther Adv Psychopharmacol. 2023. PMID: 38022835 Free PMC article.
Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial.
Shen Y, Zhao Q, Yu Y, Tan Y, Zhang H, Xu X, Wang Z, Li Y, Hu J, Zhong J, Li H. Shen Y, et al. Among authors: yu y. J Affect Disord. 2019 Oct 1;257:143-149. doi: 10.1016/j.jad.2019.07.023. Epub 2019 Jul 5. J Affect Disord. 2019. PMID: 31301615 Clinical Trial.
41,018 results
You have reached the last available page of results. Please see the User Guide for more information.